Evidence map›Paper›PMID 34503474›Full record

ArticleBMC neurology2021

Might life-threatening acute pulmonary edema occur after using recombinant tissue plasminogen activator? A case report.

Xue-Bing Chen, Dong Qu, Qing Zhang, Xia Yue, Dong-Fang Qiao

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Xue-Bing Chen *School of Forensic Medicine, Southern Medical University, 510515, Guangzhou, China.
Dong Qu *School of Forensic Medicine, Southern Medical University, 510515, Guangzhou, China.
Qing ZhangNan Fang Hospital Pharmacy Department of the Southern Medical University, 510515, Guangzhou, China.
Xia YueSchool of Forensic Medicine, Southern Medical University, 510515, Guangzhou, China.
Dong-Fang QiaoSchool of Forensic Medicine, Southern Medical University, 510515, Guangzhou, China. qiaodf@163.com.
Southern Medical University · CN

Funding

Guangzhou Sci-Tech Project 201804010307
6 · The paper itself

Abstract

backgroundRecombinant tissue plasminogen activator (rt-pa) is the first-line drug for the treatment of acute ischemic stroke, and can lead to some complications.There were rare reports of death due to acute pulmonary edema during rt-pa thrombolysis treatment. CASE PRESENTATION: This study reports a 30-year-old man was diagnosed with acute ischemic stroke and underwent rt-pa thrombolytic therapy. Finally he died despite active rescue.

conclusionsThe autopsy revealed that he died of acute pulmonary edema. This case suggests that it is necessary to pay close attention to the changes of vital signs during thrombolysis and be aware of possibility of pulmonary edema during thrombolysis.

Indexed as

Brain IschemiaPulmonary EdemaStrokeAdultFibrinolytic AgentsHumansMaleRecombinant ProteinsThrombolytic TherapyTissue Plasminogen ActivatorTreatment OutcomeFibrinolytic AgentsRecombinant ProteinsTissue Plasminogen ActivatorAcute ischemic strokeAcute pulmonary edemaCase reportForensic pathologyRecombinant tissue plasminogen activator

Identifiers

PMID34503474
PMCPMC8427873
OpenAlexW3198141738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.